演讲嘉宾

Piu Chan, MD, PhD, Professor of Neurology and Geriatrics, is the Chair of the faculty of Geriatrics and the Director of Clinical and Research Center for Parkinson’s Disease (PD), Capital Medical University. He serves as the director of National Clinical Research Center for Geriatric Disorders, and Parkinson’s Disease Center of Beijing Institutes of Brain Disorders, Xuanwu Hospital. He is also the council member of the International Association of Gerontology and Geriatrics (IAGG), past Secretary of the IAGG Asia-Oceania Region, and the deputy President of the Chinese Association of Gerontology and Geriatrics (CAGG). He has participated in the development of WHO ICOPE project and its implementation in China. He Dr. Chan has participated in drafting the Clinical Diagnostic Criteria for PD and for Prodromal PD of MDS. He published more than 400 peer reviewed SCI articles with a Google H-index of 92. Dr Chan has been the Principal Investigator for more than 10 international and domestic multi-center clinical register trials, served as consultant for NMPA-CDE. He is currently served as associate editor of Neuropharmacology and Therapy.

陈雪梅教授 1988 年获得北京⼤学学⼠学位，1995 年于美国康奈尔⼤学获博⼠学位，后在加州理⼯学院从事博⼠后研究。历任美国罗格斯⼤学瓦克斯曼研究所助理教授、副教授，加州⼤学河滨分校副教授、教授及特聘教授。曾获美国植物⽣物学家协会查尔斯·阿尔伯特·舒尔奖、马丁·吉布斯奖，南加州华裔科学家与⼯程师协会杰出成就奖，以及求是基⾦会杰出科学家奖。2011 年当选美国科学促进会会⼠，2012-2018 年担任霍华德·休斯医学研究所-⼽登与贝蒂·摩尔基⾦会研究员， 2013 年当选美国国家科学院院⼠。 2023 年全职回国发展，现任北京⼤学⽣命科学学院讲席教授、院长，核糖核酸北京研究中⼼主任。其研究领域为花器官发育、植物小 RNA和 RNA 修饰。

Before joining the Chinese University of Hong Kong as Global Stem Scholar and Professor in the Faculty of Medicine, Stephen Dalton (SD) was Professor and Endowed Chair in Molecular Cell Biology at the University of Georgia where he was founding Director of the “Center for Molecular Medicine”, and Georgia Cancer Coalition Distinguished Scholar. Originally from the UK, Dr. Dalton received his Ph.D. from the University of Adelaide in Australia, followed by post-doctoral research at the Imperial Cancer Research Fund in London, with Sir Richard Treisman. Following this, SD was appointed to the Roche Institute of Molecular Biology (Hoffman La Roche, New Jersey, USA), with an academic appointment at Columbia University in New York City. Since then, SD has continued research on the therapeutic use of stem cells. This includes collaborations with Johnson and Johnson (New Jersey, USA), Nestle’ (Lausanne, Switzerland) and Viacyte Inc. (San Diego, USA), which was recently acquired by Vertex Pharmaceuticals. Dr. Dalton’s current work focusses on developing cell-therapy and gene-editing technologies for the treatment of human disease.

馮奕斌教授自 2017 年以來連續 8 年被科睿唯安全球 ESI 評為全球前 1%⾼被引科學家，並在 2024 年獲「全球⾼被引科學家」榮譽，躋身全球前 0.1%。已發表論⽂ 630 多篇。此外，斯坦福 ⼤學也將其列為 2022-2024 全球前 2%頂尖科學家之⼀。根據 2024 年 AD 科學指數（AD scientific index），馮教授在補充與整合醫學領域為全球科學家排名世界第 7，香港第 1。

中国科学院微生物研究所学术委员会主任、中国疾病预防控制中心研究员。曾任国家自然科学基金委员会副主任、中国疾病预防控制中心主任、中国科学院微生物研究所所长等。他是新冠病毒的发现者，并主导了全球首个临床获批的新冠病毒中和抗体药物和第一个新冠病毒重组蛋白亚单位疫苗的研发。他的研究领域包括病原微生物跨宿主传播、感染机制与宿主免疫、抗病毒手段等，并涉及公共卫生政策和全球健康策略，为新发传染病防控提供重要支持。

G

郭继光，博士，河北大学基础医学院副教授、
硕士研究生导师，
主要从事帕金森病发病机制 及治疗药物研究等。2001 年获得中国科学技术大学生物系学士、
2001 年获得中国科学技术大学生物系学士、
2009 年获得中国科学院上 海生命科学学院理学博士学位，2016 年 UCLA 访问学者。
主持国家自然科学基金 1 项和多项 省级项目，
参与 973, 863 和多项国家级项目。
出版《病原生物学》等著作，在国内外期刊
Cell Research, Genome Biology, Peer J 等国际期刊上发表十多篇 SCI 论文，
并获得保定市科 技进步二等奖。

Dr. I-Ming Hsing is Professor and Former Head of Chemical and Biological Engineering at the Hong Kong University of Science and Technology (HKUST). He holds a BSc from National Taiwan University (1990) and an MSCEP and PhD from MIT (1994, 1997). Dr. Hsing’s research integrates molecular biology, reaction engineering, and micro/nanofabrication to advance nucleic acid engineering and biomaterials. His group develops innovative diagnostics, including CRISPR-based platforms for point-of-care testing and community surveillance, and nature-derived biomaterials for chronic wound care. A pioneer in molecular diagnostics, he holds multiple patents and has published extensively. Dr. Hsing serves on the editorial boards of leading journals, serves as a member of the Hong Kong SAR Government’s Research Grants Council, and is the Founding President of the Asia Pacific Biomedical Engineering Consortium, fostering collaboration in biomedical engineering and translational medicine.

Dr. Kucherlapati is the Paul C. Cabot Professor of Genetics and Professor of Medicine at the Harvard Medical School since 2001. He was the founding Director of the Harvard Partners Center for Genetics and Genomics. He obtained his PhD from the University of illinois, conducted post-doctoral studies at Yale University and held faculty positions at Princeton University. Before moving to Harvard, Dr. Kucherlapati was the University Chairman and the Lola and Saul Kramer Professor and chair of the Department of Molecular Genetics at the Albert Einstein College of Medicine in New York. Dr. Kucherlapati was a part of the Human Genome Project and the Cancer Genome Atlas project. He is a member of the National Academy of Medicine, USA.

李志光医生现任职香港中文大学儿科研究教授, 香港儿童医院顾问医生， 儿童血液肿瘤专科医生。为国际儿童癌症学会 (SIOP) 亚洲区原会长，国际 IBFM 儿童白血病研究组委员。过去多年推动香港和大陆治疗儿童癌症研究，组织参与多个香港，中国及国际白血病临床研究，2017 年香港儿童舒缓学会创会主席。科研主要于儿童血液肿瘤，细胞治疗和地中海贫血，共发表超过 400 篇科学杂志论文。
Oncology. His main interest is in childhood leukaemia, palliative care and bioethics. He has published over 400 peer-reviewed papers.